All Articles by Author:

Justin.choi

Mutation in the CCAL1 Locus Accounts for Bidirectional Process of Human Subchondral Bone Turnover and Cartilage Mineralization

[Rheumatology] OPG-XL was studied by human induced pluripotent stem cells expressing OPG-XL and two isogenic CRISPR/Cas9-corrected controls in cartilage and bone organoids.

Generation of Human Embryonic Stem Cell-Derived Lung Organoids

[STAR Protocols] This protocol describes how to generate lung organoids from human embryonic stem cells. Lung organoids form by self-assembly in Matrigel and contain lung epithelial cell types.

Patient-Derived Endometrial Organoids from MRKH Patients: Insight in Disease Causing Pathways

[Disease Models & Mechanisms] Investigators developed long-term expandable organoid cultures from endometrium found in uterine rudiment horns of Mayer-Rokitansky-Küster-Hauser (MRKH) patients.

Spontaneous Activity of the Mitochondrial Apoptosis Pathway Drives Chromosomal Defects, the Appearance of Micronuclei and Cancer Metastasis through the Caspase-Activated DNAse

[Cell Death & Disease] Inhibition of mitochondrial apoptosis or of Caspase-activated DNAse reduced the number of micronuclei in tumor cell lines as well as the number of chromosomal misalignments in tumor cells and intestinal organoids.

Fukushima Medical University Aim to Accelerate Cancer Research by Contributing Their Patient Derived Organoids to the CancerTools.org Initiative

[Fukushima Medical University (MarketScreener)] CancerTools.org, the research tools arm of Cancer Research UK, and the Fukushima Medical University and Summit Pharmaceuticals International announced a new partnership to progress their shared mission of accelerating cancer research. Through this partnership, FMU will maketheir patient derived organoids available to the global cancer research tools community.

PD-L1 and ICOSL Discriminate Human Secretory and Helper Dendritic Cells in Cancer, Allergy and Autoimmunity

[Nature Communications] Researchers showed, by using 16 different stimuli in vitro, that activated dendritic cells in human blood were phenotypically and functionally dichotomous, and pure cultures of type 2 conventional dendritic cells acquired these states upon appropriate stimuli.

Popular

Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases

[Asahi Kasei] Asahi Kasei announced the initiation of a Phase I clinical trial for AK1940, a novel peptide-based investigational compound developed to address significant unmet medical needs in patients with autoimmune diseases.

FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus

[Genentech] Genentech announced that the US FDA has accepted the company’s supplemental Biologics License Application for Gazyva® for the treatment of systemic lupus erythematosus.

Low Dose IL-2 Therapy Restores Regulatory T Cells in Patients with Systemic Lupus Erythematosus in a Dose-Dependent Manner: A Phase IIb Trial

[Nature Communications] In this multicenter, double-blind, Phase IIb trial, 152 patients with active systemic lupus erythematosus were randomized to receive subcutaneous interleukin 2 or placebo every other day for 12 weeks, then weekly for another 12 weeks. Low-dose-IL2 drove the expansion of Tregs and altered Treg/effector T cell ratios.